AmerisourceBergen has a total of 181 patents globally, out of which 95 have been granted. Of these 181 patents, more than 27% patents are active. United States of America is where AmerisourceBergen has filed the maximum number of patents, followed by Australia and Europe, it has generated an annual revenue of $189.89 billion in the year 2020. Parallelly, United States of America seems to be the main focused R&D center and is also the origin country of AmerisourceBergen.
AmerisourceBergen was formed in 2001 by the merger of Bergen Brunswig and AmeriSource. Company is doing business in pharmaceutical services. The company provides healthcare professionals with brand generic medications, over-the-counter healthcare items, home healthcare supplies and equipment, and related services. AmerisourceBergen sells their products all over the world. As of January 2022, AmerisourceBergen has a market cap of $27.65 Billion.
Do read about some of the most popular patents of AmerisourceBergen which have been covered by us in this article and also you can find AmerisourceBergen’s patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over AmerisourceBergen’s patent portfolio.
How many patents does AmerisourceBergen have?
AmerisourceBergen has a total of 181 patents globally. These patents belong to 51 unique patent families. Out of 181 patents, 50 patents are active.
How many AmerisourceBergen patents are Alive/Dead?
How Many Patents did AmerisourceBergen File Every Year?
Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.
|Year of Patents Filing or Grant||AmerisourceBergen Applications Filed||AmerisourceBergen Patents Granted|
How Many Patents did AmerisourceBergen File in Different Countries?
Countries in which AmerisourceBergen Filed Patents
|United States Of America||86|
Where are Research Centers of AmerisourceBergen Patents Located?
10 Best AmerisourceBergen Patents
US20020111832A1 is the most popular patent in the AmerisourceBergen portfolio. It has received 431 citations so far from companies like Omnicell, Z4 Technologies and Baxter International.
Below is the list of 10 most cited patents of AmerisourceBergen:
|Publication Number||Citation Count|
Which Companies are using AmerisourceBergen Patents to Advance their Research?
If patents or patents from a particular technology area of a company receive a lot of citations, it implies that the technology is being followed and incrementally innovated by the citing companies. It also indicates that citing companies are working on similar and closely related technologies.
The top citing companies in the AmerisourceBergen patent portfolio are Precision Animal Solutions, Elwha, and Aesynt Incorporated.
List of the top forward citing Companies –
|Company||Number of Patents|
|Precision Animal Solutions||3|
|Comcast Mo Group||2|
Count of 102 and 103 Type Rejections based on AmerisourceBergen Patents
Top AmerisourceBergen Patents used in Rejecting Most Patent Applications
|Patent Number||Count of Rejected Applications|
What Percentage of AmerisourceBergen US Patent Applications were Granted?
AmerisourceBergen (Excluding its subsidiaries) has filed 11 patent applications at USPTO so far (Excluding Design and PCT applications). Out of these 7 have been granted leading to a grant rate of 63.64%.
Below are the key stats of AmerisourceBergen patent prosecution at the USPTO.
Which Law Firms Filed Most US Patents for AmerisourceBergen?
|Law Firm||Total Application||Success Rate|
|Howson & Howson Llp||2||100.00%|
|Reinhart Boerner Van Deuren S C||2||100.00%|
Pharmaceutical companies and healthcare practitioners both seek to improve the lives of their patients through improving their health outcomes. Patient support programmes (PSPs) have the ability to help achieve this aim by increasing timely access to treatment and adherence to it.
AmerisourceBergen is committed to managing the pharmaceutical supply chain through pharmaceutical distribution, technology, and consulting services.
AmerisourceBergen’s solutions are intended to:
- Optimize and automate the medication management process.
- Automate tracking and control of pharmacy inventory and supplies.
- Eliminate process variations that drive up costs by automating purchasing, receiving, and dispensing.
- Improve access to supply chain management data for reporting.
- Control purchasing and procurement behaviour, and manage contract compliance.
- Support patient safety objectives through thorough use of barcoding technology.
- Maximize current capital investments by integrating with existing technologies.
- Increased capacity and staff resources redeployed from prescription filling to more patient or customer-centric tasks provide limitless opportunities to grow a business through competitive differentiation (i.e., medication packaging options,) increased capacity, and staff resources redeployed from prescription filling to more patient or customer-centric tasks.
EXCLUSIVE INSIGHTS COMING SOON!
What are AmerisourceBergen key innovation segments?
What Technologies are Covered by AmerisourceBergen?
The chart below distributes patents filed by AmerisourceBergen in different countries on the basis of the technology protected in patents. It also represents the markets where AmerisourceBergen thinks it’s important to protect particular technology inventions.
R&D Focus: How AmerisourceBergen search focus changed over the years?
EXCLUSIVE INSIGHTS COMING SOON!
Interested in knowing about the areas of innovation that are being protected by AmerisourceBergen?